Search results
Regeneron (NASDAQ: REGN) is a leading biotechnology company using the power of science to bring new medicines to patients in need. Learn more.
Regeneron Pharmaceuticals, Inc. is an American biotechnology company headquartered in Westchester County, New York. The company was founded in 1988.
Regeneron is a leading science and technology company dedicated to inventing, developing and commercializing life-transforming treatments for serious diseases. Our mission is to use the power of science to bring new medicines to patients… over and over again.
Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases.
Discover how Regeneron helps people with serious diseases by exploring our FDA-approved medicines, industrial operations, investigational pipeline and more.
Jul 30, 2021 · Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) updated the Emergency Use Authorization (EUA) for the investigational COVID-19 antibody cocktail REGEN-COV™ (casirivimab and imdevimab). The authorization now includes post-exposure prophylaxis in people at high risk for progression ...
Get the latest Regeneron Pharmaceuticals Inc (REGN) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment...
